Rekvina Laboratories Limited (BSE: 526075)
Health Care · Pharmaceuticals · IN
Rs37.28
+21.51% today · +426.6% 1Y
Rekvina Laboratories Limited (BSE: 526075) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.35M.
Over the last twelve months the share price has gained 426.6%, trading between 6.75 and 46.65.
Tweenvest scores Rekvina Laboratories Limited across four factors: quality 17/100, value 55/100. Its strongest factor is value.
526075 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.35M
- Revenue (TTM)
- $204.53K
- P/E
- —
- EPS
- -0.42
- Dividend yield
- —
- Beta (5Y)
- 2.71
- 52-week high
- Rs46.65
- 52-week low
- Rs6.75
- Avg volume (3M)
- —
- Shares outstanding
- 6.03M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.38 | +0.54% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.